PMID: 11907151Mar 22, 2002Paper

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

The Journal of Pharmacology and Experimental Therapeutics
Wolfgang Löscher, Heidrun Potschka

Abstract

Epilepsy, one of the most common neurologic disorders, is a major public health issue. Despite more than 20 approved antiepileptic drugs (AEDs), about 30% of patients are refractory to treatment. An important characteristic of pharmacoresistant epilepsy is that most patients with refractory epilepsy are resistant to several, if not all, AEDs, even though these drugs act by different mechanisms. This argues against epilepsy-induced alterations in specific drug targets as a major cause of pharmacoresistant epilepsy, but rather points to nonspecific and possibly adaptive mechanisms, such as decreased drug uptake into the brain by intrinsic or acquired over-expression of multidrug transporters in the blood-brain barrier (BBB). There is accumulating evidence demonstrating that multidrug transporters such as P-glycoprotein (PGP) and members of the multidrug resistance-associated protein (MRP) family are over-expressed in capillary endothelial cells and astrocytes in epileptogenic brain tissue surgically resected from patients with medically intractable epilepsy. PGP and MRPs in the BBB are thought to act as an active defense mechanism, restricting the penetration of lipophilic substances into the brain. A large variety of compounds, ...Continue Reading

References

Jun 7, 1991·Brain Research·L Sztriha, A L Betz
Nov 9, 1995·Biochemical Pharmacology·L JettéR Beliveau
Jan 1, 1995·The Journal of Membrane Biology·C R Leveille-Webster, I M Arias
May 1, 1996·Journal of Pain and Symptom Management·F M Ferrante
Dec 1, 1996·Immunology Letters·B SarkadiZ Holló
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·A H SchinkelP Borst
Nov 19, 1997·Progress in Neurobiology·W Löscher
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N R KoopenF Kuipers
Mar 17, 1998·Biochemical and Biophysical Research Communications·H Huai-YunD W Miller
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·V V RaoD Piwnica-Worms
Apr 21, 1999·Epilepsy Research·G Regesta, P Tanganelli
Sep 24, 1999·Neurological Research·M S LuerJ H Fischer
Dec 2, 1999·Pediatric Neurology·A LazarowskiA Rabinowicz
Dec 3, 1999·Biochimica Et Biophysica Acta·P BorstJ Wijnholds
Dec 22, 1999·Journal of Neurovirology·W M Pardridge
Mar 4, 2000·Cellular and Molecular Neurobiology·P L Golden, W M Pardridge
Mar 8, 2000·International Journal of Clinical Pharmacology and Therapeutics·M F Fromm
Mar 30, 2000·International Journal of Clinical Pharmacology and Therapeutics·A SeeligF Wohnsland
Jun 6, 2000·Advanced Drug Delivery Reviews·A H Schinkel
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Sep 7, 2000·Current Opinion in Oncology·B TanL Ratner
Feb 24, 2001·Lancet·S M SisodiyaM Thom
Feb 27, 2001·Nature Neuroscience·R H Edwards
Apr 12, 2001·The New England Journal of Medicine·T R Browne, G L Holmes
Apr 25, 2001·British Journal of Clinical Pharmacology·A OwenB K Park
Jun 21, 2001·Biochemical and Biophysical Research Communications·H SunW F Elmquist
Aug 11, 2001·Cellular and Molecular Life Sciences : CMLS·T LitmanS E Bates
Mar 7, 2002·Trends in Pharmacological Sciences·Wolfgang Löscher

❮ Previous
Next ❯

Citations

Mar 3, 2007·Archives of Pharmacal Research·Hyun-Ah KangYong-Bok Lee
Jul 8, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Goran LaćanWilliam P Melega
Feb 12, 2009·Neurosurgical Review·Mohammed F ShamjiBrien G Benoit
Mar 24, 2005·Pharmaceutical Research·Candace L GraffGary M Pollack
May 25, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Philip H ElsingaWillem Vaalburg
Jul 1, 2005·Current Neurology and Neuroscience Reports·Sanjay M Sisodiya
Jun 19, 2012·Current Psychiatry Reports·Brett A EnglishStanford Jhee
Dec 9, 2003·European Journal of Pharmacology·Margarida Castel-BrancoMargarida Caramona
Apr 7, 2004·Epilepsy Research·Juan A BarciaM Eugenia Hernández
Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Juan A Barcia, José M Gallego
Mar 7, 2002·Trends in Pharmacological Sciences·Wolfgang Löscher
Aug 2, 2002·Epilepsy Research·Wolfgang Löscher, Dieter Schmidt
Mar 1, 2003·Epilepsy & Behavior : E&B·Michael A. Rogawski
Jun 17, 2011·Expert Reviews in Molecular Medicine·Sagar AgarwalWilliam F Elmquist
Dec 3, 2010·Journal of Human Genetics·Myeong-Kyu KimMin-Ho Shin
Jun 6, 2007·Nature Clinical Practice. Neurology·Sanjay Sisodiya
Aug 16, 2003·Epilepsia·Bernhard Schaller, Stephan J Rüegg
Aug 16, 2003·Epilepsia·Eleonora AronicaDirk Troost
Feb 1, 2003·Epilepsia·V Ramachandran, Simon D Shorvon
Sep 27, 2003·Epilepsia·Antonino Pavone, Venera Cardile
Apr 11, 2003·The New England Journal of Medicine·Timothy A Pedley, Michio Hirano
Apr 11, 2003·The New England Journal of Medicine·Asra SiddiquiSanjay M Sisodiya
Aug 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Laura B JaegerAndrew V Schally
May 19, 2006·Pharmacogenetics and Genomics·Guy LeschzinerMichael R Johnson
Aug 14, 2010·Current Opinion in Oncology·Roberta RudàRiccardo Soffietti
Mar 11, 2010·Pharmacogenetics and Genomics·Laura M HodgesRuss B Altman
Dec 20, 2005·Epilepsia·Sanjay M Sisodiya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.